Illumina (ILMN) Research & Development (2009 - 2026)

Illumina (ILMN) has reported Research & Development for 18 consecutive years, with $240.0 million the latest figure, recorded in Q1 2026.

• Research & Development for Q1 2026 came in at $240.0 million, down 4.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $955.0 million (down 12.06% YoY), and the FY2025 annual result was $967.0 million, down 17.28% from the prior year.
• Research & Development was $240.0 million for Q1 2026 at Illumina, roughly flat from $239.0 million in the prior quarter.
• Over five years, Research & Development peaked at $486.0 million in Q1 2023 and troughed at $229.0 million in Q3 2025.
• Average Research & Development over 5 years is $305.6 million, with a median of $323.0 million recorded in 2022.
• Year-over-year, Research & Development jumped 63.96% in 2022 and decreased 29.84% in 2023.
• Over 5 years, Research & Development stood at $325.0 million in 2022, then climbed by 4.92% to $341.0 million in 2023, then dropped by 24.93% to $256.0 million in 2024, then slipped by 6.64% to $239.0 million in 2025, then increased by 0.42% to $240.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $240.0 million in Q1 2026, $239.0 million in Q4 2025, and $229.0 million in Q3 2025.